These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 22234621)

  • 21. Management of chronic lymphocytic leukemia (CLL) in the elderly: a position paper from an international Society of Geriatric Oncology (SIOG) Task Force.
    Stauder R; Eichhorst B; Hamaker ME; Kaplanov K; Morrison VA; Österborg A; Poddubnaya I; Woyach JA; Shanafelt T; Smolej L; Ysebaert L; Goede V
    Ann Oncol; 2017 Feb; 28(2):218-227. PubMed ID: 27803007
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Idelalisib for Treatment of Relapsed Follicular Lymphoma and Chronic Lymphocytic Leukemia: A Comparison of Treatment Outcomes in Clinical Trial Participants vs Medicare Beneficiaries.
    Bird ST; Tian F; Flowers N; Przepiorka D; Wang R; Jung TH; Kessler Z; Woods C; Kim B; Miller BW; Wernecke M; Kim C; McKean S; Gelperin K; MaCurdy TE; Kelman JA; Graham DJ
    JAMA Oncol; 2020 Feb; 6(2):248-254. PubMed ID: 31855259
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mapping comorbidity in chronic lymphocytic leukemia: impact of individual comorbidities on treatment, mortality, and causes of death.
    Rotbain EC; Niemann CU; Rostgaard K; da Cunha-Bang C; Hjalgrim H; Frederiksen H
    Leukemia; 2021 Sep; 35(9):2570-2580. PubMed ID: 33603143
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Erythropoietin and chronic lymphocytic leukemia.
    Mauro FR; Gentile M; Foa R
    Rev Clin Exp Hematol; 2002; Suppl 1():21-31. PubMed ID: 12735212
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Treatment of patients with chronic lymphocytic leukemia].
    Mucsi O
    Magy Onkol; 2016 Jun; 60(2):127-36. PubMed ID: 27275639
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Chronic lymphocytic leukemia accompanied by renal failure].
    Dzhumbaeva BT; Biriukova LS; Gemdzhian EG; Kravchenko SK; Melikian AL; Roshtina LS
    Ter Arkh; 2014; 86(12):37-41. PubMed ID: 25804038
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A review of pharmacologic options for previously untreated chronic lymphocytic leukemia.
    Wilhelm K; Yang D
    J Oncol Pharm Pract; 2011 Jun; 17(2):91-103. PubMed ID: 20085962
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacotherapeutic Management of Chronic Lymphocytic Leukaemia in Patients with Comorbidities: New Agents, New Hope.
    Goede V; Hallek M
    Drugs Aging; 2015 Nov; 32(11):877-86. PubMed ID: 26446155
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chronic lymphocytic leukemia-associated autoimmune hemolytic anemia.
    D'Arena G; Cascavilla N
    Leuk Lymphoma; 2007 Jun; 48(6):1072-80. PubMed ID: 17577769
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pentostatin in chronic lymphocytic leukemia.
    Sauter C; Lamanna N; Weiss MA
    Expert Opin Drug Metab Toxicol; 2008 Sep; 4(9):1217-22. PubMed ID: 18721115
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New modalities of therapy in chronic lymphocytic leukemia.
    Cheson BD
    Crit Rev Oncol Hematol; 1991 Sep; 11(3):167-77. PubMed ID: 1958310
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Key issues in the treatment of chronic lymphocytic leukaemia (CLL).
    Catovsky D; Murphy RL
    Eur J Cancer; 1995 Dec; 31A(13-14):2146-54. PubMed ID: 8652233
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment and management of chronic lymphocytic leukemia in the elderly: what the pharmacist clinician should know.
    Johnson TM
    Consult Pharm; 2012 Apr; 27(4):274-85. PubMed ID: 22498987
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Current approaches to the treatment and management of chronic lymphocytic leukaemia.
    Montserrat E; Rozman C
    Drugs; 1994; 47 Suppl 6():1-9. PubMed ID: 7525184
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chronic lymphocytic leukemia: diagnosis and treatment.
    Yee KW; O'Brien SM
    Mayo Clin Proc; 2006 Aug; 81(8):1105-29. PubMed ID: 16901035
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic factors in chronic lymphocytic leukemia-what do we need to know?
    Cramer P; Hallek M
    Nat Rev Clin Oncol; 2011 Jan; 8(1):38-47. PubMed ID: 20956983
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A review of supportive care and recommended preventive approaches for patients with chronic lymphocytic leukemia.
    Randhawa JK; Ferrajoli A
    Expert Rev Hematol; 2016 Mar; 9(3):235-44. PubMed ID: 26652692
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Optimal management of older patients with chronic lymphocytic leukemia: some facts and principles guiding therapeutic choices.
    Tadmor T; Polliack A
    Blood Rev; 2012 Jan; 26(1):15-23. PubMed ID: 21955980
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The HOVON68 CLL trial revisited: performance status and comorbidity affect survival in elderly patients with chronic lymphocytic leukemia.
    Vojdeman FJ; Van't Veer MB; Tjønnfjord GE; Itälä-Remes M; Kimby E; Polliack A; Wu KL; Doorduijn JK; Alemayehu WG; Wittebol S; Kozak T; Walewski J; Abrahamse-Testroote MC; van Oers MH; Geisler CH
    Leuk Lymphoma; 2017 Mar; 58(3):594-600. PubMed ID: 27484290
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recent progress in the management of chronic lymphocytic leukemia.
    Robak T
    Cancer Treat Rev; 2007 Dec; 33(8):710-28. PubMed ID: 17904294
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.